Entourage announced today its financial results for the three months ended March 31, 2023.

Entourage Health Corp. announced today that the Company's first quarter 2023 financial results will be released after market close on Monday, May 29, 2023.

Entourage Health Corp. announced today its financial results for the fiscal year ended December 31, 2021.

Entourage Health Corp. announced today that it will file its financial statements and management’s discussion and analysis for the fourth quarter and fiscal year ended December 31, 2022, by Monday, May 1, 2023.

Entourage Health Corp. announced today that it will file its financial statements and management’s discussion and analysis for the fourth quarter and fiscal year ended December 31, 2022, after market close on Thursday, April 27, 2023.

Entourage Health Corp. announced today that, in accordance with the provisions of its omnibus equity incentive compensation plan, the Company has authorized the issuance of an aggregate of 1,600,000 deferred share units to non-management directors of the Company as compensation for their services.

Entourage Health Corp. is pleased to announce the expansion of its medical portfolio with the launch of a new CBD chewing gum available to Starseed patients on the Company’s medical platform.

Entourage Health Corp. is pleased to announce the expansion of its brand portfolio with new offerings.

Entourage Health Corp. is pleased to announce it has successfully closed the second $15 million tranche of its upsized credit facility with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada, as announced on October 31, 2022.

Entourage Health Corp. is pleased to announce Color Cannabis as a winner of the 2022 ADCANN Award for Canadian Marketing Campaign of the Year.

Entourage Health Corp. confirmed today it has signed an amendment to its senior secured amended and restated credit facility entered into on October 28, 2022.

Entourage announced today its financial results for the three and nine months ended September 30, 2022.

HEXO Corp., a leading producer of high-quality cannabis products, today announced the execution of a long-term supply agreement with Entourage Health Corp., a Canadian producer and distributor of award-winning cannabis products.

Entourage Health Corp. announced today it will file its third quarter 2022 financial statements and management’s discussion and analysis after-market on Monday November 14, 2022.

Entourage Health Corp. is pleased to announce it has amended and upsized its existing credit facility with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada, adding an additional $30 million in funding availability.

Entourage Health Corp. is pleased to announce the expansion of its premium brand portfolio releasing its most extensive suite of new products into the Canadian market to date.

Entourage Health Corp. is pleased to announce the launch of Syndicate a direct-to-patient medical cannabis marketplace showcasing a portfolio of premium craft cannabis products sourced both in-house and from third-party micro-cultivators and producers.

Entourage Health Corp. is pleased to announce the appointment of James Afara as the Company’s Chief Operating Officer (COO).

Entourage Health Corp. is pleased to announce its medical subsidiary Starseed Medicinal has added four new union groups to its full-service, proprietary medical cannabis program, in partnership with leading benefits provider Union Benefits – the administrator of union group benefits to over 12,000 members.

Entourage announced today its financial results for the three and six months ended June 30, 2022.